Results 101 to 110 of about 607 (121)

Aging-rewired metabolic cues promote autophagy and senescence via DRAM1. [PDF]

Autophagy
Yang J, Sun H, Xu K, Zhang X, Huang M, Jin G, Liu Y, Chen W, Lin S, Shen J, Zhong CQ, Xu Y, Zhang Q, Liu W, Yang Y, Ou J.   +15 more
europepmc   +1 more source

Validation of a measure of contraceptive self-injection self-efficacy in Uganda. [PDF]

BMC Womens Health
Bullington BW, Challa S, Wasswa R, Amongin D, Birabwa C, Nanono S, Waiswa P, Cover J, Holt K.   +8 more
europepmc   +1 more source

The WHO Medical Eligibility Criteria for Contraceptive Use 6th edition and the WHO Selected Practice Recommendations 4th edition: update and future direction. [PDF]

BMJ Sex Reprod Health
Kidula N, Kiarie JN.
europepmc   +1 more source

Nursing student training as a novel approach to increasing community-based access to contraception in the Democratic Republic of the Congo: evaluation of outcomes. [PDF]

Health Policy Plan
Akilimali P, Compta G, Ngondo D, Koba T, Kayembe D, Kabasubabo F, Akamba F, Mujani Z, Lusamba P, Binanga A, Hernandez J, Sauter S, Bertrand JT.   +12 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Would you be interested in DMPA-SC? An implementation project in two urban primary care clinics

Contraception, 2022
Self-administered DMPA-SC has similar efficacy to DMPA-IM with potential benefits. We conducted an implementation study to assess interest in and successful use of DMPA-SC for patients using DMPA-IM. Four physicians telephoned patients with DMPA-IM on their medication list in two urban primary care clinics and offered counseling and prescriptions to ...
Christina Miles, Deepthi Ennamuri, Jaquelyn Yeh, Grace Shih   +3 more
openaire   +2 more sources

Contraceptive efficacy and safety of DMPA-SC

Contraception, 2004
DMPA-SC 104 mg/0.65 mL is a new, low-dose subcutaneous (SC) formulation of Depo-Provera contraceptive injection (150 mg/mL medroxyprogesterone acetate injectable suspension) that provides efficacy, safety and immediacy of onset equivalent to Depo-Provera intramuscular (IM) injection.
J, Jain, A J, Jakimiuk, F R, Bode, D, Ross, A M, Kaunitz   +4 more
openaire   +2 more sources

Society of Family Planning committee consensus on self-administration of subcutaneous depot medroxyprogesterone acetate (DMPA-SC)

Contraception, 2022
Depot medroxyprogesterone acetate (DMPA) is a highly-effective, injectable contraceptive method that requires injections every 12 to 15 weeks. The need for return visits to a healthcare provider may present barriers to access, use, and continuation of DMPA.
Julia E, Kohn, Elise D, Berlan, Jennifer H, Tang, Anitra, Beasley   +3 more
openaire   +2 more sources

Acceptability of Contraceptive Self-Injection with DMPA-SC Among Adolescents in Gulu District, Uganda

International Perspectives on Sexual and Reproductive Health, 2017
In Uganda, an estimated one in four adolescent women have begun childbearing. Many adolescent pregnancies are unintended because of substantial barriers to contraceptive access. The injectable contraceptive is the most commonly used method in Uganda, and a new subcutaneous version offers the possibility of reducing access barriers by offering a self ...
Jane, Cover, Jeanette, Lim, Allen, Namagembe, Justine, Tumusiime, Jennifer Kidwell, Drake, Carie Muntifering, Cox   +5 more
openaire   +2 more sources